MarketScreener Strategies Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Other stock markets
|
After hours 19:59:02 | |||
| 529.59 USD | +0.29% |
|
501.41 | -5.32% |
| 01:54am | PRESS DIGEST-Wall Street Journal - July 7 | RE |
| 09:11pm | Vertex Pharmaceuticals Incorporated, Crinetics Pharmaceuticals, Inc. - M&A Call |
MarketScreener Strategies
Search
 | Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 05:47 am |
 | Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 09:35 am |
 | Vertex Pharmaceuticals : A very promising pipeline | January 11, 2023 at 05:20 am |
No results match your criteria
- Stock Market
- Stocks
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
